Format

Send to:

Choose Destination
See comment in PubMed Commons below
Immunol Allergy Clin North Am. 2013 Nov;33(4):471-85. doi: 10.1016/j.iac.2013.07.003. Epub 2013 Aug 26.

Creating a comprehensive treatment plan for hereditary angioedema.

Author information

  • 1Division of Rheumatology, Allergy and Immunology, University of California - San Diego, 9500 Gilman Dr., La Jolla, CA 92093, USA. Electronic address: mriedl@mednet.ucla.edu.

Abstract

Management of hereditary angioedema (HAE) has changed dramatically in recent years because of the availability of several HAE-specific medications. This paradigm shift in therapy provides the opportunity to dramatically improve the care of HAE patients, but has increased the complexity of treatment. Patient education and communication with health care providers is crucial. Early treatment of HAE attacks has been shown to improve clinical outcomes, highlighting the importance of rapid and reliable treatment. This review summarizes the current evidence for best practices in HAE management, and suggests practical steps toward developing a comprehensive treatment plan.

Copyright © 2013 Elsevier Inc. All rights reserved.

KEYWORDS:

C1INH deficiency; Hereditary angioedema; Therapy; Treatment plan

PMID:
24176212
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk